(Q52022309)

English

Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.

scientific article published on 29 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

protein evolution

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Morito Kurata

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Maki Hasegawa

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Yasunori Nakagawa

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Shinya Abe

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Kouhei Yamamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Kenshi Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Masanobu Kitagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

publication date

29 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

81

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

249-254

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Acute myeloid leukemia in the elderly: biology and therapeutic strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of the multidrug resistance-associated protein in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.01.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YEXMP.2006.01.004

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/16566920

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52022309&oldid=1382486593"